164 related articles for article (PubMed ID: 22998939)
1. Foveal vision is impaired in Parkinson's disease.
Bodis-Wollner I
Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
[TBL] [Abstract][Full Text] [Related]
2. Fovea and foveation in Parkinson's disease.
Bodis-Wollner I; Glazman S; Yerram S
Behav Neurosci; 2013 Apr; 127(2):139-50. PubMed ID: 23356330
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
Lee JY; Ahn J; Kim TW; Jeon BS
J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
[TBL] [Abstract][Full Text] [Related]
4. Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
[TBL] [Abstract][Full Text] [Related]
5. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
[TBL] [Abstract][Full Text] [Related]
6. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
Miri S; Glazman S; Mylin L; Bodis-Wollner I
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S134-7. PubMed ID: 26414119
[TBL] [Abstract][Full Text] [Related]
7. A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.
Slotnick S; Ding Y; Glazman S; Durbin M; Miri S; Selesnick I; Sherman J; Bodis-Wollner I
Mov Disord; 2015 Oct; 30(12):1692-5. PubMed ID: 26340519
[TBL] [Abstract][Full Text] [Related]
8. Retinal nerve fiber layer thinning in Parkinson disease.
Inzelberg R; Ramirez JA; Nisipeanu P; Ophir A
Vision Res; 2004 Nov; 44(24):2793-7. PubMed ID: 15342223
[TBL] [Abstract][Full Text] [Related]
9. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
[TBL] [Abstract][Full Text] [Related]
10. Update on visual function and choroidal-retinal thickness alterations in Parkinson's disease.
Obis J; Satue M; Alarcia R; Pablo LE; Garcia-Martin E
Arch Soc Esp Oftalmol (Engl Ed); 2018 May; 93(5):231-238. PubMed ID: 29454631
[TBL] [Abstract][Full Text] [Related]
11. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
[TBL] [Abstract][Full Text] [Related]
12. Venturing into the no-man's land of the retina in Parkinson's disease.
Bodis-Wollner I; Miri S; Glazman S
Mov Disord; 2014 Jan; 29(1):15-22. PubMed ID: 24339212
[TBL] [Abstract][Full Text] [Related]
13. Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI.
Kupersmith MJ; Mandel G; Anderson S; Meltzer DE; Kardon R
J Neurol Sci; 2011 Sep; 308(1-2):117-23. PubMed ID: 21764408
[TBL] [Abstract][Full Text] [Related]
14. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
[TBL] [Abstract][Full Text] [Related]
15. Visual dysfunction in Parkinson's disease.
Rodnitzky RL
Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
[TBL] [Abstract][Full Text] [Related]
16. The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease.
Pinkhardt EH; Ding Y; Slotnick S; Kassubek J; Ludolph AC; Glazman S; Selesnick I; Bodis-Wollner I
J Neural Transm (Vienna); 2020 Sep; 127(9):1275-1283. PubMed ID: 32676747
[TBL] [Abstract][Full Text] [Related]
17. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
[TBL] [Abstract][Full Text] [Related]
18. Retinopathy in Parkinson Disease.
Bodis-Wollner I
J Neural Transm (Vienna); 2009 Nov; 116(11):1493-501. PubMed ID: 19730784
[TBL] [Abstract][Full Text] [Related]
19. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
Nowacka B; Lubiński W; Honczarenko K; Potemkowski A; Safranow K
Doc Ophthalmol; 2015 Oct; 131(2):95-104. PubMed ID: 25972299
[TBL] [Abstract][Full Text] [Related]
20. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
